COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Arthur Klausner will be a panelist at the New York Biotechnology Association's Annual Meeting
News | 04. 17. 2006
